Perifosine enhances bevacizumab-induced apoptosis and therapeutic efficacy by targeting PI3K/AKT pathway in a glioblastoma heterotopic model
Crossref DOI link: https://doi.org/10.1007/s10495-017-1382-2
Published Online: 2017-06-14
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ramezani, Sara
Vousooghi, Nasim
Ramezani Kapourchali, Fatemeh
Joghataei, Mohammad Taghi
Funding for this research was provided by:
Iran University of Medical Sciences (24164)
Iran National Science Foundation (IR) (92035151)
License valid from 2017-06-14